Evidence map›Paper›PMID 35428543›Full record

ArticleRevue d'epidemiologie et de sante publique2022

Who is hesitant about Covid-19 vaccines? The profiling of participants in a French online cohort.

Ilaria Montagni, Kevin Ouazzani-Touhami, Aude Pouymayou, Edwige Pereira, Nathalie Texier, Stéphane Schück, Christophe Tzourio, CONFINS group

Open access · greenAbstract read
In one paragraph

Article in Revue d'epidemiologie et de sante publique, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. COVID-19 vaccine literacy: A scoping review.Human vaccines & immunotherapeutics · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Ilaria MontagniUniv.Bordeaux, Inserm, Bordeaux Population Health Research Center, U1219, F-33000, Bordeaux, France. Electronic address: ilaria.montagni@u-bordeaux.fr.
Kevin Ouazzani-TouhamiUniv.Bordeaux, Inserm, Bordeaux Population Health Research Center, U1219, F-33000, Bordeaux, France; Polyclinique Inkermann, groupe Elsan, 79000 Niort, France.
Aude PouymayouUniv.Bordeaux, Inserm, Bordeaux Population Health Research Center, U1219, F-33000, Bordeaux, France.
Edwige PereiraUniv.Bordeaux, Inserm, Bordeaux Population Health Research Center, U1219, F-33000, Bordeaux, France.
Nathalie TexierKap Code, F-75010 Paris, France; Kappa Santé, F-75002 Paris, France.
Stéphane SchückKap Code, F-75010 Paris, France; Kappa Santé, F-75002 Paris, France.
Christophe TzourioUniv.Bordeaux, Inserm, Bordeaux Population Health Research Center, U1219, F-33000, Bordeaux, France.
CONFINS groupUniv.Bordeaux, Inserm, Bordeaux Population Health Research Center, U1219, F-33000, Bordeaux, France; Polyclinique Inkermann, groupe Elsan, 79000 Niort, France; Kap Code, F-75010 Paris, France; Kappa Santé, F-75002 Paris, France.
Inserm · FRParis Biotech Santé · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo report the characteristics of vaccine-hesitant individuals in a French-speaking adult population in the context of the SARS-CoV-2 pandemic; and to identify predictors of hesitancy about Covid-19-related vaccines.

methodsBetween April and May 2020, 1640 French-speaking adults participating in an online cohort were classified according to their attitudes towards vaccination as: "hesitant", "anti-vaccination", and "pro-vaccination". Descriptive statistics, univariate multinomial regression models and multivariate analyses were compiled and carried out.

resultsAt the time of inclusion, compared to pro-vaccination participants, hesitant participants were more frequently females (p=0.044), not annually vaccinated against flu (p=0.026), less optimistic about the discovery of a treatment against Covid-19 in a few months (p<0.001), less ready to undergo this treatment (p<0.001), presenting less trust in the ability of public health authorities to control the pandemic (p=0.036) and reporting lower scores on knowledge-related scales (p values from <0.001 to 0.002). Univariate analyses confirmed these results with odds ratios ranging from 1.51 [1.05-2.17] to 2.19 [1.56-3.07]. In the multivariate models, the remaining variables associated with hesitant compared to pro-vaccination attitudes were discovery of a treatment against Covid-19 in a few months (OR=2.57 [1.73-3.81]), being ready to undergo this treatment (OR=7.07 [4.89-10.22]), digital vaccine literacy (OR=1.70 [1.14-2.54]) and general health literacy (OR=1.49 [1.03-2.15]). DISCUSSION: In a continuum of relative acceptance of Covid-19-related vaccines, hesitant individuals were situated in between the behaviours and characteristics of pro-vaccination and anti-vaccination groups. While their characteristics were in line with the literature, this study was the first to report data on health literacy, digital vaccine literacy and capacity to detect fake news associated with vaccine hesitancy.

conclusionsWhile failing to identify straightforward predictors, findings suggest that continued education and communication campaigns focused on improving vaccine literacy, particularly among women younger than 35 years, could heighten the proportion of persons accepting vaccination.

Indexed as

COVID-19VaccinesAdultCOVID-19 VaccinesCross-Sectional StudiesFemaleHumansSARS-CoV-2VaccinationCOVID-19 VaccinesVaccinesCohortCohorteCovid-19Hésitation vaccinaleProfilProfilingVaccine hesitancy

Identifiers

PMID35428543
PMCPMC8958178
OpenAlexW4220725922

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.